Unique ID issued by UMIN | UMIN000040430 |
---|---|
Receipt number | R000046138 |
Scientific Title | Ultrasound-guided central venipuncture using pocket-sized versus standard ultrasound devices: a prospective non-inferiority trial |
Date of disclosure of the study information | 2020/05/19 |
Last modified on | 2020/11/11 21:05:46 |
Ultrasound-guided central venipuncture using pocket-sized ultrasound device
Ultrasound-guided central venipuncture using pocket-sized ultrasound device
Ultrasound-guided central venipuncture using pocket-sized versus standard ultrasound devices: a prospective non-inferiority trial
Ultrasound-guided central venipuncture using pocket-sized versus standard ultrasound devices: a prospective non-inferiority trial
Japan |
Subjects 20 to 85 years of age with American Society of Anesthesiologists Physical Status 1 or 2 who underwent scheduled surgery with general anesthesia and right internal jugular vein catheter placement
Cardiology | Surgery in general | Gastrointestinal surgery |
Hepato-biliary-pancreatic surgery | Vascular surgery | Chest surgery |
Obstetrics and Gynecology | Dermatology | Urology |
Anesthesiology | Neurosurgery | Cardiovascular surgery |
Adult |
Malignancy
NO
To investigate the non-inferiority of pocket-sized ultrasound devices for ultrasound-guided internal jugular venipuncture in comparison with standard ultrasound devices by evaluating the differences in their performance
Safety,Efficacy
Not applicable
puncture time between the venipuncture and imaging guidewire placement by ultrasound devices
number of punctures, artificial(guidewire and needle) visibility, and anatomic visibility by ultrasound devices
Interventional
Parallel
Randomized
Individual
Single blind -participants are blinded
Active
Numbered container method
2
Treatment
Device,equipment |
Central venipuncture using Vscan Dual Probe (GE Healthcare, Tokyo, Japan) as a pocket-sized ultrasound device (PUD): Group P.
Central venipuncture using SonoSite EDGE and HFL 50/15-6 linear probe (SonoSite Japan Co., Tokyo, Japan) as a standard ultrasound device (SUD) : Group S.
20 | years-old | <= |
85 | years-old | >= |
Male and Female
20 to 85 years of age with American Society of Anesthesiologists Physical Status 1 or 2 who underwent scheduled surgery with general anesthesia and right internal jugular vein catheter placement
The following exclusion criteria were applied: patients with skin abnormalities in the neck region, abnormally running right cervical blood vessels, venous thrombus during the ultrasound prescan, collapse of the right cervical blood vessels during the ultrasound prescan, history of cervical radiation or operation, body mass index 35 kg/m2 or higher, or severe pulmonary complications.
56
1st name | Kenji |
Middle name | |
Last name | Yamamoto |
Nayoro City General Hospital
Dept. of Anesthesia
0968511
1, minami 8 - nishi 7, Nayoro-city, Hokkaido, Japan
01654-3-3101
cab55640@yahoo.co.jp
1st name | Kenji |
Middle name | |
Last name | Yamamoto |
Nayoro City General Hospital
Dept. of Anesthesia
0968511
1, minami 8 - nishi 7, Nayoro-city, Hokkaido, Japan
01654-3-3101
cab55640@yahoo.co.jp
Nayoro City General Hospital
no funding sources
Self funding
Nayoro City General Hospital
1, minami 8 - nishi 7, Nayoro-city, Hokkaido, Japan
01654-3-3101
cab55640@yahoo.co.jp
NO
名寄市立総合病院(北海道)
2020 | Year | 05 | Month | 19 | Day |
Unpublished
56
Our findings indicate that PUDs for internal jugular venipuncture have non-inferiority to SUDs with regard to puncture time and number of punctures, despite differences in the visualization potential and device performance.
2020 | Year | 11 | Month | 11 | Day |
Delay expected |
under publishing
We recruited subjects 20 to 85 years of age with American Society of Anesthesiologists Physical Status 1 or 2 who underwent scheduled surgery with general anesthesia and right internal jugular vein catheter placement between May 20, 2020 and August 31, 2020.
General anesthesia was induced in all patients by infusion of remifentanil (0.3 mcg/kg/min), rocuronium (0.6 mg/kg), and propofol (single-shot of 2 mg/kg or 2.0 to 3.0 mcg/ml using a target-controlled infusion system). General anesthesia was maintained by remifentanil, rocuronium, and propofol or sevoflurane. The ventilator settings were pressure-controlled mechanical ventilation at maximum inspiratory pressure < 20 cmH2O and positive end-expiratory pressure of 5 cmH2O to achieve end-tidal carbon dioxide between 35-40 cmH2O. After induction, all patients were randomly assigned to 1 of 2 groups using sealed opaque envelopes and random number tables that were computer generated by an independent assistant: PUD group (Group P) and SUD group (Group S).
non
The primary endpoint was puncture time, and the secondary endpoints included number of punctures, artificial visibility, and anatomic visibility.
non
non
Completed
2018 | Year | 05 | Month | 06 | Day |
2017 | Year | 10 | Month | 05 | Day |
2020 | Year | 05 | Month | 20 | Day |
2020 | Year | 08 | Month | 31 | Day |
2020 | Year | 09 | Month | 10 | Day |
2020 | Year | 09 | Month | 10 | Day |
2020 | Year | 09 | Month | 10 | Day |
2020 | Year | 05 | Month | 18 | Day |
2020 | Year | 11 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046138
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |